CJC 1295 / Ipamorelin

CJC-1295 / Ipamorelin in Laboratory Research

This vial contains two peptides that act on the growth-hormone axis through different receptors. CJC-1295 is a GHRH analog engaging the GHRH receptor; Ipamorelin is a selective agonist at the ghrelin receptor, GHS-R1a.

Combining them is a standard approach in preclinical work examining growth-hormone secretion, since the two receptor pathways converge on the same somatotroph population. The pre-blended format removes a compounding step from the experiment.

Research Applications & Study Focus

The blend is used in studies of growth-hormone secretion pulsatility, somatotroph signalling, and comparative pharmacology of the GHRH and ghrelin-receptor pathways.

Both components are assayed separately, and their results appear on the batch certificate, so investigators know exactly what each vial contains.

Purity, Handling & Verification

Each batch is supplied as a sealed, lyophilized vial and is independently analysed by a third-party laboratory using HPLC and mass spectrometry; the full certificate of analysis is published against its lot number, so results can be verified before use. Both components are assayed separately, with all results reported on the batch certificate. Store the lyophilized material cool, dry and out of direct light, and reconstitute with bacteriostatic water under standard aseptic laboratory practice.

This material is offered strictly for in vitro laboratory research use only. It is not for human or veterinary consumption, and not for diagnostic or therapeutic use.